APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Propofol Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Propofol Drug Market Outlook and Growth Opportunities 2026

Report ID 174029120427 December 2025209 pages

Choose your research edition.

Industry ResearchPropofol Drug Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Propofol Drug Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Propofol Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propofol Drug Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Propofol Drug Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Propofol Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Propofol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Propofol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Propofol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Propofol Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Propofol Drug market include Xi’an Libang Pharmaceutical, Sichuan Kelun Pharmaceutical, Jiangsu Yingke Biopharmaceutical, Guangdong Jiabo Pharmaceutical, Jiangsu Nhwa Pharmaceutical, Beijing Sciecure Pharmaceutical, Sichuan Biokin Pharmaceutical, Wellona Pharma and Rusoma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Propofol Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Propofol Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Propofol Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Propofol Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Propofol Drug Segment by Company

Xi’an Libang Pharmaceutical

Sichuan Kelun Pharmaceutical

Jiangsu Yingke Biopharmaceutical

Guangdong Jiabo Pharmaceutical

Jiangsu Nhwa Pharmaceutical

Beijing Sciecure Pharmaceutical

Sichuan Biokin Pharmaceutical

Wellona Pharma

Rusoma

Pfizer

NEON

Fresenius Kabi

Flagship Biotech

Dr. Reddy's Laboratories

Centurion Healthcare

B. Braun

Aspen Pharma

Propofol Drug Segment by Type

50 mL

20 mL

100 mL

10 mL

Propofol Drug Segment by Application

Mechanical Ventilation

General Anesthesia

Medical Procedures Sedation

Other

Propofol Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Propofol Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Propofol Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Propofol Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Propofol Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propofol Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Propofol Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Propofol Drug industry.

Chapter 3: Detailed analysis of Propofol Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Propofol Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Propofol Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Propofol Drug Industry Trends Table 2. Propofol Drug Industry Drivers Table 3. Propofol Drug Industry Opportunities and Challenges Table 4. Propofol Drug Industry Restraints Table 5. Global Propofol Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Propofol Drug Revenue Share by Company (2021-2026) Table 7. Global Propofol Drug Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Propofol Drug Sales Volume Share by Company (2021-2026) Table 9. Global Propofol Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Propofol Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Propofol Drug Key Company Manufacturing Base & Headquarters Table 12. Global Propofol Drug Company, Product Type & Application Table 13. Global Propofol Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Propofol Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 50 mL Table 18. Significant Companies of 20 mL Table 19. Significant Companies of 100 mL Table 20. Significant Companies of 10 mL Table 21. Global Propofol Drug Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 22. Global Propofol Drug Sales Volume by Type (2021-2026) & (M Units) Table 23. Global Propofol Drug Sales Volume by Type (2027-2032) & (M Units) Table 24. Global Propofol Drug Sales Volume Share by Type (2021-2026) Table 25. Global Propofol Drug Sales Volume Share by Type (2027-2032) Table 26. Global Propofol Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Propofol Drug Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Propofol Drug Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Propofol Drug Sales Value Share by Type (2021-2026) Table 30. Global Propofol Drug Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Mechanical Ventilation Table 32. Significant Companies of General Anesthesia Table 33. Significant Companies of Medical Procedures Sedation Table 34. Significant Companies of Other Table 35. Global Propofol Drug Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 36. Global Propofol Drug Sales Volume by Application (2021-2026) & (M Units) Table 37. Global Propofol Drug Sales Volume by Application (2027-2032) & (M Units) Table 38. Global Propofol Drug Sales Volume Share by Application (2021-2026) Table 39. Global Propofol Drug Sales Volume Share by Application (2027-2032) Table 40. Global Propofol Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Propofol Drug Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Propofol Drug Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Propofol Drug Sales Value Share by Application (2021-2026) Table 44. Global Propofol Drug Sales Value Share by Application (2027-2032) Table 45. Global Propofol Drug Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 46. Global Propofol Drug Sales by Region (2021-2026) & (M Units) Table 47. Global Propofol Drug Sales Market Share by Region (2021-2026) Table 48. Global Propofol Drug Sales by Region (2027-2032) & (M Units) Table 49. Global Propofol Drug Sales Market Share by Region (2027-2032) Table 50. Global Propofol Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Propofol Drug Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Propofol Drug Sales Value Share by Region (2021-2026) Table 53. Global Propofol Drug Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Propofol Drug Sales Value Share by Region (2027-2032) Table 55. Global Propofol Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Propofol Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Propofol Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 58. Global Propofol Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Propofol Drug Sales by Country (2021-2026) & (M Units) Table 60. Global Propofol Drug Sales Market Share by Country (2021-2026) Table 61. Global Propofol Drug Sales by Country (2027-2032) & (M Units) Table 62. Global Propofol Drug Sales Market Share by Country (2027-2032) Table 63. Global Propofol Drug Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Propofol Drug Sales Value Market Share by Country (2021-2026) Table 65. Global Propofol Drug Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Propofol Drug Sales Value Market Share by Country (2027-2032) Table 67. Xi’an Libang Pharmaceutical Company Information Table 68. Xi’an Libang Pharmaceutical Business Overview Table 69. Xi’an Libang Pharmaceutical Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Xi’an Libang Pharmaceutical Propofol Drug Product Portfolio Table 71. Xi’an Libang Pharmaceutical Recent Development Table 72. Sichuan Kelun Pharmaceutical Company Information Table 73. Sichuan Kelun Pharmaceutical Business Overview Table 74. Sichuan Kelun Pharmaceutical Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sichuan Kelun Pharmaceutical Propofol Drug Product Portfolio Table 76. Sichuan Kelun Pharmaceutical Recent Development Table 77. Jiangsu Yingke Biopharmaceutical Company Information Table 78. Jiangsu Yingke Biopharmaceutical Business Overview Table 79. Jiangsu Yingke Biopharmaceutical Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Jiangsu Yingke Biopharmaceutical Propofol Drug Product Portfolio Table 81. Jiangsu Yingke Biopharmaceutical Recent Development Table 82. Guangdong Jiabo Pharmaceutical Company Information Table 83. Guangdong Jiabo Pharmaceutical Business Overview Table 84. Guangdong Jiabo Pharmaceutical Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Guangdong Jiabo Pharmaceutical Propofol Drug Product Portfolio Table 86. Guangdong Jiabo Pharmaceutical Recent Development Table 87. Jiangsu Nhwa Pharmaceutical Company Information Table 88. Jiangsu Nhwa Pharmaceutical Business Overview Table 89. Jiangsu Nhwa Pharmaceutical Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Jiangsu Nhwa Pharmaceutical Propofol Drug Product Portfolio Table 91. Jiangsu Nhwa Pharmaceutical Recent Development Table 92. Beijing Sciecure Pharmaceutical Company Information Table 93. Beijing Sciecure Pharmaceutical Business Overview Table 94. Beijing Sciecure Pharmaceutical Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Beijing Sciecure Pharmaceutical Propofol Drug Product Portfolio Table 96. Beijing Sciecure Pharmaceutical Recent Development Table 97. Sichuan Biokin Pharmaceutical Company Information Table 98. Sichuan Biokin Pharmaceutical Business Overview Table 99. Sichuan Biokin Pharmaceutical Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Sichuan Biokin Pharmaceutical Propofol Drug Product Portfolio Table 101. Sichuan Biokin Pharmaceutical Recent Development Table 102. Wellona Pharma Company Information Table 103. Wellona Pharma Business Overview Table 104. Wellona Pharma Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Wellona Pharma Propofol Drug Product Portfolio Table 106. Wellona Pharma Recent Development Table 107. Rusoma Company Information Table 108. Rusoma Business Overview Table 109. Rusoma Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Rusoma Propofol Drug Product Portfolio Table 111. Rusoma Recent Development Table 112. Pfizer Company Information Table 113. Pfizer Business Overview Table 114. Pfizer Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Pfizer Propofol Drug Product Portfolio Table 116. Pfizer Recent Development Table 117. NEON Company Information Table 118. NEON Business Overview Table 119. NEON Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. NEON Propofol Drug Product Portfolio Table 121. NEON Recent Development Table 122. Fresenius Kabi Company Information Table 123. Fresenius Kabi Business Overview Table 124. Fresenius Kabi Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Fresenius Kabi Propofol Drug Product Portfolio Table 126. Fresenius Kabi Recent Development Table 127. Flagship Biotech Company Information Table 128. Flagship Biotech Business Overview Table 129. Flagship Biotech Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Flagship Biotech Propofol Drug Product Portfolio Table 131. Flagship Biotech Recent Development Table 132. Dr. Reddy's Laboratories Company Information Table 133. Dr. Reddy's Laboratories Business Overview Table 134. Dr. Reddy's Laboratories Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Dr. Reddy's Laboratories Propofol Drug Product Portfolio Table 136. Dr. Reddy's Laboratories Recent Development Table 137. Centurion Healthcare Company Information Table 138. Centurion Healthcare Business Overview Table 139. Centurion Healthcare Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Centurion Healthcare Propofol Drug Product Portfolio Table 141. Centurion Healthcare Recent Development Table 142. B. Braun Company Information Table 143. B. Braun Business Overview Table 144. B. Braun Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. B. Braun Propofol Drug Product Portfolio Table 146. B. Braun Recent Development Table 147. Aspen Pharma Company Information Table 148. Aspen Pharma Business Overview Table 149. Aspen Pharma Propofol Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Aspen Pharma Propofol Drug Product Portfolio Table 151. Aspen Pharma Recent Development Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Propofol Drug Distributors List Table 155. Propofol Drug Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Propofol Drug Product Image Figure 2. Global Propofol Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Propofol Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Propofol Drug Sales (2021-2032) & (M Units) Figure 5. Global Propofol Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Propofol Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 50 mL Image Figure 10. 20 mL Image Figure 11. 100 mL Image Figure 12. 10 mL Image Figure 13. Global Propofol Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 14. Global Propofol Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Propofol Drug Sales Volume Share by Type (2021-2032) Figure 16. Global Propofol Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Propofol Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Propofol Drug Sales Value Share by Type (2021-2032) Figure 19. Mechanical Ventilation Image Figure 20. General Anesthesia Image Figure 21. Medical Procedures Sedation Image Figure 22. Other Image Figure 23. Global Propofol Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 24. Global Propofol Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Propofol Drug Sales Volume Share by Application (2021-2032) Figure 26. Global Propofol Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Propofol Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Propofol Drug Sales Value Share by Application (2021-2032) Figure 29. Global Propofol Drug Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 30. Global Propofol Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Propofol Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Propofol Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Propofol Drug Sales Value (2021-2032) & (US$ Million) Figure 34. North America Propofol Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Propofol Drug Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Propofol Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Propofol Drug Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Propofol Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Propofol Drug Sales Value (2021-2032) & (US$ Million) Figure 40. South America Propofol Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Propofol Drug Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Propofol Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Propofol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Propofol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Propofol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Propofol Drug Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Propofol Drug Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • 50 mL
  • 20 mL
  • 100 mL
  • 10 mL
Applications
  • Mechanical Ventilation
  • General Anesthesia
  • Medical Procedures Sedation
  • Other
Companies covered
  • Xi’an Libang Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Jiangsu Yingke Biopharmaceutical
  • Guangdong Jiabo Pharmaceutical
  • Jiangsu Nhwa Pharmaceutical
  • Beijing Sciecure Pharmaceutical
  • Sichuan Biokin Pharmaceutical
  • Wellona Pharma
  • Rusoma
  • Pfizer
  • NEON
  • Fresenius Kabi
  • Flagship Biotech
  • Dr. Reddy's Laboratories
  • Centurion Healthcare
  • B. Braun
  • Aspen Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Propofol Drug Sales Value (2021-2032)
  4. 1.2.2 Global Propofol Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Propofol Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Propofol Drug Market Dynamics
  1. 2.1 Propofol Drug Industry Trends
  2. 2.2 Propofol Drug Industry Drivers
  3. 2.3 Propofol Drug Industry Opportunities and Challenges
  4. 2.4 Propofol Drug Industry Restraints
3 Propofol Drug Market by Company
  1. 3.1 Global Propofol Drug Company Revenue Ranking in 2025
  2. 3.2 Global Propofol Drug Revenue by Company (2021-2026)
  3. 3.3 Global Propofol Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Propofol Drug Average Price by Company (2021-2026)
  5. 3.5 Global Propofol Drug Company Ranking (2024-2026)
  6. 3.6 Global Propofol Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Propofol Drug Company Product Type and Application
  8. 3.8 Global Propofol Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Propofol Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Propofol Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Propofol Drug Market by Type
  1. 4.1 Propofol Drug Type Introduction
  2. 4.1.1 50 mL
  3. 4.1.2 20 mL
  4. 4.1.3 100 mL
  5. 4.1.4 10 mL
  6. 4.2 Global Propofol Drug Sales Volume by Type
  7. 4.2.1 Global Propofol Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Propofol Drug Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Propofol Drug Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Propofol Drug Sales Value by Type
  11. 4.3.1 Global Propofol Drug Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Propofol Drug Sales Value by Type (2021-2032)
  13. 4.3.3 Global Propofol Drug Sales Value Share by Type (2021-2032)
5 Propofol Drug Market by Application
  1. 5.1 Propofol Drug Application Introduction
  2. 5.1.1 Mechanical Ventilation
  3. 5.1.2 General Anesthesia
  4. 5.1.3 Medical Procedures Sedation
  5. 5.1.4 Other
  6. 5.2 Global Propofol Drug Sales Volume by Application
  7. 5.2.1 Global Propofol Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Propofol Drug Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Propofol Drug Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Propofol Drug Sales Value by Application
  11. 5.3.1 Global Propofol Drug Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Propofol Drug Sales Value by Application (2021-2032)
  13. 5.3.3 Global Propofol Drug Sales Value Share by Application (2021-2032)
6 Propofol Drug Regional Sales and Value Analysis
  1. 6.1 Global Propofol Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Propofol Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Propofol Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Propofol Drug Sales by Region (2027-2032)
  5. 6.3 Global Propofol Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Propofol Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Propofol Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Propofol Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Propofol Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Propofol Drug Sales Value (2021-2032)
  12. 6.6.2 North America Propofol Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Propofol Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Propofol Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Propofol Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Propofol Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Propofol Drug Sales Value (2021-2032)
  21. 6.9.2 South America Propofol Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Propofol Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Propofol Drug Sales Value Share by Country, 2025 VS 2032
7 Propofol Drug Country-level Sales and Value Analysis
  1. 7.1 Global Propofol Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Propofol Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Propofol Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Propofol Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Propofol Drug Sales by Country (2027-2032)
  6. 7.4 Global Propofol Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Propofol Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Propofol Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Propofol Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Propofol Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Propofol Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Propofol Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Propofol Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Propofol Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Propofol Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Propofol Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Propofol Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Propofol Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Propofol Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Propofol Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Propofol Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Propofol Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Propofol Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Propofol Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Propofol Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Propofol Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Propofol Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Propofol Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Propofol Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Propofol Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Propofol Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Propofol Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Propofol Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Propofol Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Propofol Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Propofol Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Propofol Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Propofol Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Propofol Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Propofol Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Propofol Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Propofol Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Propofol Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Propofol Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Propofol Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Propofol Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Propofol Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Propofol Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Propofol Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Propofol Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Propofol Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Propofol Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Propofol Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Propofol Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Propofol Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Propofol Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Propofol Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Propofol Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Propofol Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Propofol Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Propofol Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Propofol Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Propofol Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Propofol Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Propofol Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Propofol Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Propofol Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Propofol Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Propofol Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Propofol Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Propofol Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Propofol Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Propofol Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Propofol Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Propofol Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Propofol Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Propofol Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Propofol Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Propofol Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Propofol Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Propofol Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Propofol Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Propofol Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Propofol Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Propofol Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Propofol Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Propofol Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Propofol Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Propofol Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Propofol Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Propofol Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Propofol Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Xi’an Libang Pharmaceutical
  2. 8.1.1 Xi’an Libang Pharmaceutical Company Information
  3. 8.1.2 Xi’an Libang Pharmaceutical Business Overview
  4. 8.1.3 Xi’an Libang Pharmaceutical Propofol Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Xi’an Libang Pharmaceutical Propofol Drug Product Portfolio
  6. 8.1.5 Xi’an Libang Pharmaceutical Recent Developments
  7. 8.2 Sichuan Kelun Pharmaceutical
  8. 8.2.1 Sichuan Kelun Pharmaceutical Company Information
  9. 8.2.2 Sichuan Kelun Pharmaceutical Business Overview
  10. 8.2.3 Sichuan Kelun Pharmaceutical Propofol Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Kelun Pharmaceutical Propofol Drug Product Portfolio
  12. 8.2.5 Sichuan Kelun Pharmaceutical Recent Developments
  13. 8.3 Jiangsu Yingke Biopharmaceutical
  14. 8.3.1 Jiangsu Yingke Biopharmaceutical Company Information
  15. 8.3.2 Jiangsu Yingke Biopharmaceutical Business Overview
  16. 8.3.3 Jiangsu Yingke Biopharmaceutical Propofol Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Jiangsu Yingke Biopharmaceutical Propofol Drug Product Portfolio
  18. 8.3.5 Jiangsu Yingke Biopharmaceutical Recent Developments
  19. 8.4 Guangdong Jiabo Pharmaceutical
  20. 8.4.1 Guangdong Jiabo Pharmaceutical Company Information
  21. 8.4.2 Guangdong Jiabo Pharmaceutical Business Overview
  22. 8.4.3 Guangdong Jiabo Pharmaceutical Propofol Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Guangdong Jiabo Pharmaceutical Propofol Drug Product Portfolio
  24. 8.4.5 Guangdong Jiabo Pharmaceutical Recent Developments
  25. 8.5 Jiangsu Nhwa Pharmaceutical
  26. 8.5.1 Jiangsu Nhwa Pharmaceutical Company Information
  27. 8.5.2 Jiangsu Nhwa Pharmaceutical Business Overview
  28. 8.5.3 Jiangsu Nhwa Pharmaceutical Propofol Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jiangsu Nhwa Pharmaceutical Propofol Drug Product Portfolio
  30. 8.5.5 Jiangsu Nhwa Pharmaceutical Recent Developments
  31. 8.6 Beijing Sciecure Pharmaceutical
  32. 8.6.1 Beijing Sciecure Pharmaceutical Company Information
  33. 8.6.2 Beijing Sciecure Pharmaceutical Business Overview
  34. 8.6.3 Beijing Sciecure Pharmaceutical Propofol Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Beijing Sciecure Pharmaceutical Propofol Drug Product Portfolio
  36. 8.6.5 Beijing Sciecure Pharmaceutical Recent Developments
  37. 8.7 Sichuan Biokin Pharmaceutical
  38. 8.7.1 Sichuan Biokin Pharmaceutical Company Information
  39. 8.7.2 Sichuan Biokin Pharmaceutical Business Overview
  40. 8.7.3 Sichuan Biokin Pharmaceutical Propofol Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sichuan Biokin Pharmaceutical Propofol Drug Product Portfolio
  42. 8.7.5 Sichuan Biokin Pharmaceutical Recent Developments
  43. 8.8 Wellona Pharma
  44. 8.8.1 Wellona Pharma Company Information
  45. 8.8.2 Wellona Pharma Business Overview
  46. 8.8.3 Wellona Pharma Propofol Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Wellona Pharma Propofol Drug Product Portfolio
  48. 8.8.5 Wellona Pharma Recent Developments
  49. 8.9 Rusoma
  50. 8.9.1 Rusoma Company Information
  51. 8.9.2 Rusoma Business Overview
  52. 8.9.3 Rusoma Propofol Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Rusoma Propofol Drug Product Portfolio
  54. 8.9.5 Rusoma Recent Developments
  55. 8.10 Pfizer
  56. 8.10.1 Pfizer Company Information
  57. 8.10.2 Pfizer Business Overview
  58. 8.10.3 Pfizer Propofol Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Pfizer Propofol Drug Product Portfolio
  60. 8.10.5 Pfizer Recent Developments
  61. 8.11 NEON
  62. 8.11.1 NEON Company Information
  63. 8.11.2 NEON Business Overview
  64. 8.11.3 NEON Propofol Drug Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 NEON Propofol Drug Product Portfolio
  66. 8.11.5 NEON Recent Developments
  67. 8.12 Fresenius Kabi
  68. 8.12.1 Fresenius Kabi Company Information
  69. 8.12.2 Fresenius Kabi Business Overview
  70. 8.12.3 Fresenius Kabi Propofol Drug Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Fresenius Kabi Propofol Drug Product Portfolio
  72. 8.12.5 Fresenius Kabi Recent Developments
  73. 8.13 Flagship Biotech
  74. 8.13.1 Flagship Biotech Company Information
  75. 8.13.2 Flagship Biotech Business Overview
  76. 8.13.3 Flagship Biotech Propofol Drug Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Flagship Biotech Propofol Drug Product Portfolio
  78. 8.13.5 Flagship Biotech Recent Developments
  79. 8.14 Dr. Reddy's Laboratories
  80. 8.14.1 Dr. Reddy's Laboratories Company Information
  81. 8.14.2 Dr. Reddy's Laboratories Business Overview
  82. 8.14.3 Dr. Reddy's Laboratories Propofol Drug Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Dr. Reddy's Laboratories Propofol Drug Product Portfolio
  84. 8.14.5 Dr. Reddy's Laboratories Recent Developments
  85. 8.15 Centurion Healthcare
  86. 8.15.1 Centurion Healthcare Company Information
  87. 8.15.2 Centurion Healthcare Business Overview
  88. 8.15.3 Centurion Healthcare Propofol Drug Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Centurion Healthcare Propofol Drug Product Portfolio
  90. 8.15.5 Centurion Healthcare Recent Developments
  91. 8.16 B. Braun
  92. 8.16.1 B. Braun Company Information
  93. 8.16.2 B. Braun Business Overview
  94. 8.16.3 B. Braun Propofol Drug Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 B. Braun Propofol Drug Product Portfolio
  96. 8.16.5 B. Braun Recent Developments
  97. 8.17 Aspen Pharma
  98. 8.17.1 Aspen Pharma Company Information
  99. 8.17.2 Aspen Pharma Business Overview
  100. 8.17.3 Aspen Pharma Propofol Drug Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Aspen Pharma Propofol Drug Product Portfolio
  102. 8.17.5 Aspen Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Propofol Drug Value Chain Analysis
  2. 9.1.1 Propofol Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Propofol Drug Sales Mode & Process
  6. 9.2 Propofol Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Propofol Drug Distributors
  9. 9.2.3 Propofol Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst